BIXT — Bioxytran Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Bioxytran, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.17	0.042	0.072	0.295	0.026
Net Total Accounts Receivable
Net Total Receivables	0.05	—	—	—	—
Prepaid Expenses
Total Current Assets	0.22	0.316	0.072	0.295	0.026
Net Intangible Assets
Total Assets	0.22	0.326	0.119	0.371	0.138
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.02	2.27	3.28	3.66	3.25
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	1.02	3.16	2.88	3.07	2.57
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.799	-2.83	-2.76	-2.7	-2.43
Total Liabilities & Shareholders' Equity	0.22	0.326	0.119	0.371	0.138
Total Common Shares Outstanding
Total Preferred Shares Outstanding